A Randomized Controlled Trial of the Effects of Vitamin D on Muscle Strength and Mobility in Older Women with Vitamin D Insufficiency

Kun Zhu, PhD; Nicole Austin, PhD; Amanda Devine, PhD; David Bruce, MD; Richard L. Prince, MD


J Am Geriatr Soc. 2010;58(11):2063-2068. 

In This Article

Abstract and Introduction


Objectives: To evaluate the effects of vitamin D treatment on muscle strength and mobility in older women with vitamin D insufficiency.
Design: One-year population-based, double-blind, randomized, controlled trial.
Setting: Perth, Australia (latitude 32°S).
Participants: Three hundred two community-dwelling ambulant elderly women aged 70 to 90 with a serum 25-hydroxyvitamin D (25(OH)D) concentration less than 24 ng/mL.
Intervention: Vitamin D2 1,000 IU/d or identical placebo; calcium citrate (1 g calcium/d) in both groups.
Measurements: Lower limb muscle strength and mobility as assessed using the Timed Up and Go Test (TUAG).
Results: At baseline, mean±standard deviation serum 25(OH)D was 17.7±4.2 ng/mL; this increased to 24.0±5.6 ng/mL in the vitamin D group after 1 year but remained the same in the placebo group. For hip extensor and adductor strength and TUAG, but not for other muscle groups, a significant interaction between treatment group and baseline values was noted. In those with baseline values in the lowest tertile, vitamin D improved muscle strength and TUAG more than calcium alone (mean (standard error): hip extensors 22.6% (9.5%); hip adductors 13.5% (6.7%), TUAG 17.5% (7.6%), P<.05). Baseline 25(OH)D levels did not influence patient response to supplementation.
Conclusion: Vitamin D therapy was observed to increase muscle function in those who were the weakest and slowest at baseline. Vitamin D should be given to people with insufficiency or deficiency to improve muscle strength and mobility.


Older people are at risk of inadequate vitamin D production in the skin because of less sun exposure and poorer ability of the skin to synthesize vitamin D.[1] Low vitamin D status has been implicated as a cause of falling in elderly institutionalized women[2,3] and in community-dwelling women.[4,5] Despite this, the mechanism of action of vitamin D on falls propensity remains unclear and is an important question that arises in conjunction with the question of clinical efficacy. It has been suggested that the effects of vitamin D on de novo protein synthesis mediates its effects on muscle[6,7] through receptors for 1,25(OH)2D in muscle tissue. Specifically, it has been suggested that it is the active vitamin D metabolite (1,25(OH)2D) that binds to a specific vitamin D nuclear receptor (VDR) in the muscle tissue.[8–10]

Several cross-sectional studies have shown that low vitamin D status is related to lower muscle strength and lower physical performance in older people,[11–14] but prospective randomized controlled trials on potential mechanisms have not provided a clear answer. Whereas some vitamin D supplementation studies showed an effect of vitamin D on improving lower extremity muscle strength and function in older people,[2,15,16] others have failed to show any effect.[17–19]

Moreover, there are few studies on the effects of vitamin D supplementation on muscle strength and mobility in older people with low vitamin D status, although a recent study has suggested benefit on mediolateral sway in participants who had large sway at baseline.[20] The aim of this study was to compare the effects of vitamin D2 treatment 1,000 IU/d with placebo for 1 year on muscle strength and mobility in older community-dwelling women with vitamin D insufficiency. The beneficial effects of the intervention on falls risk have been published previously.[5]


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.